Literature DB >> 11349481

Social anxiety disorder.

B A Raj1, D V Sheehan.   

Abstract

In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11349481     DOI： 10.1016/s0025-7125(05)70337-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  3 in total

1.  Have drug companies hyped social anxiety disorder to increase sales. No: Efforts to relieve human suffering deserve rewards.

Authors:  D V Sheehan
Journal:  West J Med       Date:  2001-12

2.  A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trial.

Authors:  Naoki Yoshinaga; Fumiyo Ohshima; Satoshi Matsuki; Mari Tanaka; Tomomi Kobayashi; Hanae Ibuki; Kenichi Asano; Osamu Kobori; Tetsuya Shiraishi; Emi Ito; Michiko Nakazato; Akiko Nakagawa; Masaomi Iyo; Eiji Shimizu
Journal:  BMC Res Notes       Date:  2013-02-28

3.  Structural and functional connectivity changes in the brain associated with shyness but not with social anxiety.

Authors:  Xun Yang; Keith Maurice Kendrick; Qizhu Wu; Taolin Chen; Sunima Lama; Bochao Cheng; Shiguang Li; Xiaoqi Huang; Qiyong Gong
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.